Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer

World Journal of Surgery

Volumn 25, Issue 8, 2001, Pages 996-1001

  Crowe, Philip J ^a   Yang, Jia Lin ^a   Berney, Christophe R ^a   Erskine, Catherine ^a   Ham, John M ^a   Fisher, Richard ^a   Russell, Pamella J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; PARAFFIN; PROTEIN P53; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; DNA CONTENT; FEMALE; FLOW CYTOMETRY; GENETIC MARKER; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE C ERB; ONCOGENE C MYC; ONCOGENE H RAS; PREDICTION; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENETIC MARKERS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; SURVIVAL RATE;

EID: 0034889875     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-001-0069-5     Document Type: Article

References (35)

1. Surgical options in the treatment of hepatic metastasis from colorectal cancer
2. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of long-term survivors
3. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases
4. Level of serum gastrin as a predictor of liver metastasis from colorectal cancer
5. The clinicopathologic features of serum CA 19-9-positive colorectal cancers
6. Prognostic significance of DNA content abnormalities and measurements of cell proliferation
7. DNA flow-cytometric analysis in colorectal cancer: A comparison of metastasizing and non-metastasizing tumours
8. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence
9. Possible prognostic significance of p53 immunoreactive status of hepatic colorectal cancer metastases following surgical resection
10. Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers
11. K-ras status does not predict successful hepatic resection of colorectal cancer metastasis
12. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: Efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models
13. Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors
14. Determinants of survival following hepatic resection for metastatic colorectal cancer
15. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases
16. Colorectal cancer: Hepatic-directed therapy - The role of surgery, regional chemotherapy, and novel modalities
17. Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome
18. Repeated hepatectomy for colorectal metastasis
19. Repeat hepatic resection for recurrent colorectal cancer
20. Repeat liver resections from colorectal metastasis: Repeat hepatic resection registry
21. Analysis of hepatic recurrence of colorectal cancer after resection of hepatic metastases
22. Formal hepatic resection of colorectal liver metastases: Ploidy and prognosis
23. Tumor DNA content in primary and metastatic colorectal carcinoma
24. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas
25. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer
26. P53 nuclear overexpression: An independent predictor of survival in lymph node-positive colorectal cancer patients
27. P53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
28. Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer
29. P53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma
30. Prediction of recurrence in B-C stages of colorectal cancer by p53 nuclear overexpression in comparison with standard pathological features
31. Chromosome allele loss in colorectal liver metastases and its association with clinical features
32. A novel function for the nm23-H1 gene: Overexpression in human breast carcinoma cells to the formation of basement membrane and growth arrest
33. Reduced expression of nm23 protein is associated with advanced tumour stage and distant metastases in human colorectal carcinomas
34. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis
35. Protein markers in colorectal cancer: Predictors of liver metastasis